Proteomic Analysis of Systemic Sclerosis Serum Identifies the Toll-Like Receptor Agonists S100a8/A9 as a Novel Possible Pathogenic Marker

Journal of Translational Medicine - United Kingdom
doi 10.1186/1479-5876-8-s1-p67
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

S100a8/A9 Complex

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Toll Like Receptors in Systemic Sclerosis: An Emerging Target

Immunology Letters
AllergyImmunology
2018English

Serum IL-15 in Patients With Early Systemic Sclerosis: A Potential Novel Marker of Lung Disease

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2007English

Harnessing the Immune System to Fight Cancer With Toll-Like Receptor and RIG-I-like Receptor Agonists

Pharmacological Research
Pharmacology
2020English

Clinical Value of Serum S100a8/A9 and CA15-3 in the Diagnosis of Breast Cancer

2019English

Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists

Frontiers in Immunology
AllergyImmunology
2019English

Serum Amyloid a 3 (SAA3); Toll-Like Receptor 4 (TLR4)

Science-Business eXchange
2008English

Serum Levels of Leptin Receptor in Patients With Systemic Sclerosis

Intractable and Rare Diseases Research
Medicine
2013English

Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy